Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Apr 06, 2011 2:51pm
362 Views
Post# 18394791

he looks for technology’s impact in unusual places

he looks for technology’s impact in unusual places

The Tech market is looking good

If technology stocks are currently underpriced, then now is the time to get in
By Ian Harvey
April 6, 2011

It’s the road not taken that haunts most. Or, perhaps the stock not bought. And with the tech sector on the rebound, investors will increasingly wonder if they should be buying in. Case in point: in 1997 Apple’s stock had tanked and the company was on the brink of insolvency. Iconic founder Steve Jobs returned and Microsoft CEO Bill Gates announced an investment of $150 million into Apple, citing the importance of the Macintosh to its Office suite. It was a lifeline and set the stage for Jobs to hit a home run with the iMac.

Fourteen years later, Apple stock is north of US$356, and if Microsoft had hung on to that investment, it would be worth US$5.43 billion today.

With the tech-laden NASDAQ surging back like old times, could it be we’re set for a new era of dot-com activity much like in the late nineties before it all crashed in 2000?

Well, probably not. What’s different this time around is that tech stocks are lagging the field. The big industrials have fared better since the 2009 crash. “Technology stocks are so much cheaper than industrials right now,” said Francois Campeau at Triology Advisors, who manages CI Global Science and Technology fund, an industry award-winning mutual fund.

Campeau prefers software and hardware makers who feed off the spending of industrials. Thus, with the industrials back on solid footing, an IT spending cycle on upgraded PCs, servers, software and networking infrastructure is about to be unleashed.

It adds up to revenues which, in turn, will drive interest in share prices. “We’re already starting to see it in the software segment,” Campeau said. “SAP (XETRA:SAP.DE) had some strong numbers, as did (tech consultants) Accenture (ACN:US) and Oracle (NASDAQ:ORCL), which is a sign of strong demand from capital spending.”

Further, market capitalization for tech (the market value of all shares of a sector) as a percentage value of GDP is “clearly below the historic trend.” Taken in context with PE ratios (the stock price against company earnings per share), that suggests technology stocks are underpriced across the board.

Hewlett Packard (NYSE:HPQ), for example, recently had a PE of between 10 and 9.2, Campeau said, while the S&P average PE was 13.9. The business side of HP just keeps scoring highly: “They’re really evolved and extended. They’re a lot more like IBM, which is good.”

There are still some crazy valuations, much like during the dot-com boom when PE ratios soared into three figures as investors bet on future earnings, but generally, investors are a lot more cautious since the 2009 crash.

Still, predicting stock prices isn’t a science. Consider this: last year, 41 Wall St. analysts collectively predicted Apple’s (NASDAQ:AAPL) stock would hit US$428 within a year. On Feb. 18 it was US$350, a 20 per cent gap. Even then, Apple investors saw a better than 80 per cent return on their money if they bought last August at US$240, but the analysts were still off.

As we crawl out from under the wreckage of the recession, it’s the numbers that should do the talking, said BirchLeaf Investments founder Bob Floyd. “I look for devices that people want to use and that are functional and really have a place in the market first. But what I also want to see is revenue, (profit) margins and growth.”

It’s also important to look at the stage of the company’s business cycle, he said. Are customers ready to start buying? Have they completed their purchases and upgrades. Catching a good company at the start of its sales cycle could mean good growth in stock prices.

“What I don’t want are conceptual stocks: an idea which really isn’t in production yet or has no channels to get to market,” he said.

Look beyond the obvious

Of course, the technology sector extends far beyond Dell, HP, Microsoft (NASDAQ:MSFT), Intel (NASDAG:INTC) and Cisco. It encompasses health-care technologies, communications, nanotech, alternative energies and others. Floyd, for one, is leery of the alternative energy sector from an investment perspective, saying it’s a little early to pick winners.

ATS Automation Tooling Systems (TSX: ATA ) is a good example of this, he said. With offices in Canada, the U.S., France and China, it makes automation systems for factories to churn out high-tech devices and is itself a solar panel maker. Its new CEO has been cost cutting and reorganizing and is planning to break off the solar division to concentrate on the manufacturing equipment business. Floyd takes from this that the core business is doing well but the “glamour” division, the one making solar panels, is facing growing competition as others get into the market and margins shrink.

On the other hand, he looks for technology’s impact in unusual places. Food production, for example, is shifting into high gear amid global fears of shortages and rising prices, which means farmers will need to invest in new equipment.

Hemisphere GPS (TSX:HEM), a maker of tractor GPS navigation units, might be benefitting from this. The units monitor a tractor’s path down to a few centimetres, so fertilizer doesn’t overlap and burn the crop or go to waste. It does the same for seed. Hemisphere’s more advanced systems can automatically steer a tractor, so once a path is laid out, it can make that run again and again automatically.
Bullboard Posts